Вы находитесь на странице: 1из 9

,

,
, -

...
,
,

...
 . IgE 
 , ..
. (k )
,  . 
,  IgE :
. ,  Fab, , Fc, 
 
, . [Haupt M.T., Carl
son R.W., 1989].

:
I ( ), II 
, III , IV 
( ).

I , 
, , , 
. 
, 

().

 
.
, 
.

, . . 1. .

: , 
,  . 
.   , 0,5
(, ),  1% .
(,  
, ). ,
  , . 
,  
. 
. (. ).
 
(
),  , 
 
[Roizen M.F., 1990]. . 
 
(Ig), 
, (),
2/99

. ( 
 ,
: , 
IgG, IgD, IgE, IgM IgA. I  ;
IgE.
(. 1), 

32
).  , 

, .
, 1 
. , 
 . 
, ( 2 ,
,  , ,
) (  , 
, )  .
, 2
. , 
 [Moroy T., Sedlacek H.H., 1995].
. , 

[Haupt M.T., Carlson R.W., 1989]. , 
.
: 
in vitro , ,
 , .
 
.  ,
 20 ( 
[ eicosa).
.., 1990; ., .., 1991]. , (
(),  ), (). 
,
. I ,
, II 
.  . 
, ,
(  
 . , 
), . . 
()  
 (. 2).
, : 1) 
1 2. 1  ,
, ,  , 2)
. .
2/99

. 2. .

33
 C4, D4, E4, B4. 
, , 
. 
 , 
(): A, B, C, D, E, F, G, H, I. 
.
,  D2, F2 ( 
, ,  ) E2 ( 
, . ).
.

(G2 H2). ( 20), , , 
( 
 , .
 
). , ,
:  . , 
1 , .. , 
 . 
, 2 , , 
 ,
.
.
G2 H2  (. 3). .. 
H2, F2, D2,  +, 
. H2  (1),
 
2  (2 4), 
(I2). 2 (3). 
 
2 6F1 [ ., 5 9. 
., 1986]. (), 
, ,  3 .
. , , 
, ( .. ),
, , [Moroy T., Sedlacek H.H., 1995].
, , 
,  . 
 , 9, 
.
 , 
(  . , 
, 
) 5 
(5) ,
, 
5
, , 
().
A4 B4 ,
, D4 E4.

[Rei
ness H.D., Halushka P.V., 1989].
2 ,
, .

, 
. 
2/99



,
.

. 3. .

34
 .  ,
() ,
[Jacob H.S., 1989]. 
 ,
.  (
3 , 
5 ,  ).
,  
, 
.  . 
 
. , 
,  . , 
,
, ,  , 
.  , 
, .
.


,  1 
,  , 
[ .., 1991]. .
, 

. IgE. 
 , 
.
. I ( 
) . 

. 
. 
( ; ,
),  ;
( ,
), (  [Laurence D.R., Bennett P.N., 1980].

, 0,7 10% [ .., .., 1982; Lau
, ).  rence D.R., Bennett P.N., 1980], , , 
IgE,
0,002% [Roizen M.F.,
. 1990].
II ()  
 
IgE   (; 
, , , ; 
. ; ; ).
III ()  
 : 28% 
,  
. [ .., 1991]. 
, , 
, 

IgE . . , , 
  , 
 , 
, (
IgE. ,   
2/99

),
 ( 
, . ). 
,
, : [Kapsunik J.E. et al., 1989].

35
1. ,


, , , IgE-
(, ), (
.. ), , ,
, , , ,
, , ,
,
, , , .
, , , , -
, , , ,
, -
,

()  
). , , 
. ( ),
(), (, ); , , , .
(, ),  ,
(), (, ),  . , 
(, ), ( ,
, ). ,
,
[ ,
.., 1987]. . 
.
,  
,  , , 
. , , .
 3. .
30% . 
 
, (
.  
 ).
, 4. (,
. ). 
 . 
[Strichartz G.R., Covi ,
no B.G., 1990]. .
,  
1% .
(99%
 . 
). 
, 
 .
. . , 
1. /  .
,  
. 
, : 
() , ,
.  , 
  . 
2/99


(  : , 
). , , , 
2.  , , ,
,  ,
(  , , 

36
, . .
. , ,
 , , 
 ,
,  . 
.  , ,
,  , ,
, ,
. . 
 ,
,  . 
.  .
, 
 , ,
. , . 


.  , 
 .
. , 
. T.Almen,
P.Aspelin (1995), (  . 
) 
(,  . 
, , , ,  , . 
, ) 10% ,
( , ,
) 
1:9001:3000, , 
1:500001:100000.  , 
(, , , 
, , , ),  . .
, 
. 
( 
Ig , , 
, ,  )
() , 
, , , . 
. 
. 

: , ,
,  , , , 
 ,  , , .
, .


: , 
 ( 
 
, ), (
 
. , , ), (
, 
, , , ), (
.  ).
, , .  
 : , 
,  , , , [
2/99

, , .  .., 1983; .. ., 1984].




, 
. I 
.

37
1.  son R.W., 1993].
, 
 ,
( 
). /
( 
. ).
2. II . 1. .
. , 
,
(  , 
 
 , . 
, ), , 
 , 
.  ,
 . 
/
. 56 / 20 

.  0,20,9 //.
2.
. , 
3. .  . 
(
 24 /), (48 /), 
.  (36 //).
2 
, 1 , , ,
 
.
, . 3. 1

(/) 
, . 
(/) 0,30,8 
1:10000.  . 
 10 /
( 46 .
,  4.
, .
) / 300
(  5 [Yarough J.A. et al., 1989; Marshall G.D.,
 Lieberman P.L., 1991].
), 

.
4. 
. , .
, 1. ()
.  (), 
, ,  , .
. 2.
:
 ) 
 :
. ,
,  (in vitro);
 :
.  ,
2/99

 ,
;
. ) ;
) 
[Imm A., Carl .

38
2.
(M.M.Fisher, . .., 1990)

 , 
, 
 IgE, 125I; 

.  ), (
in vitro , IgE, 125I, 
 IgE, ,
. ,
,  , 
.  ) . [ .., 1990].
,  
Ig  .
,
. . 
 IgE 
, ,
,  .
, (. 
. , , , , patch)

 , 
.  . 
,  , 
, ( (
) [Laxenaire M.C. et al., )
1990]. 
. 
, 
, , , .

2/99

. , . 
: 20 
(  . (
,  3 ) .
 ,
), (  .

39
 .. . .: ,
(,  1987. 160 .
), / . .
, .. . : , 1991. 152 .
,  . . : , 1991. 328 .
(  ., . . : -
).  , 1986. 336 .
(prick) Sedlacek H.-H., Moroy T. Immune reactions. Headlines, over-
. views, tables and graphics. Berlin, Heidelberg: Springer-Verlag,
20 , , 1995. 581 p.
.  26 1999 .
.
 : , ,
1:1000  , ,
/ 0,02 .

, , .
.., ..
 -
..Fisher, . -
 - -
, . 2 (. -
.. , 1990). ,  ,
, Z.M. Wen et .
al. (1992), 500 /. . -
IgE -
 , -
,  , -
 , .
,  , -
 .
. 
ANAPHYLACTIC SHOCK
. 
Dubitsky A., Belyaev A.

In clause the modem representations about an anaphylactic
.
shock are resulted. The characteristic of the basic structurally
1 2
functional components of an anaphylactic shock is resulted, the
( 24 , .. 
detailed characteristic biologically of active substances partic-

ipating in realization of allergic reaction is resulted. The con-
), 
cepts of anaphylactic and anaphylactoid reactions are differen-
( 2 ). ,
tiated. The basic mechanisms of occurrence of allergic reaction

sowing to application frequently of used preparations are
.
resulted, especially antibiotics, local anaesthetics, radiographic
substances are characterized from these positions. In clause
.. - are described clinic and therapy of an anaphylactic shock, and
. : , 1990. 176 . also methods of its prophylaxis.
.. .
: , 1983. 160 .

2/99

40

Оценить